New research predicts a "substantial rise" in uterine cancer cases and deaths in the U.S. through 2050, with Black women most ...

One study suggested little or no difference in rates of ovarian hyperstimulation syndrome between LOD and gonadotrophins (OR 0.08, 95% CI 0.00 to 1.61, 1 study, 33 women, low-quality evidence). There ...

Breast Cancer (BC) is a predominant cause of mortality among women globally, with its incidence progressively rising due to various causes. Early detection of BC is crucial to plan and execute ...

Glucagon-like peptide-1 (GLP-1) receptor agonists significantly enhance overall survival in patients with ovarian cancer, offering a promising adjunct to traditional treatments.

The investigational CDK2 inhibitor INCB123667 showed encouraging anti-tumor activity with manageable toxicity in patients with heavily pretreated resistant/refractory ovarian cancer, according to ...

After collecting ultrasound features and B3GALT4 mRNA expression data of breast cancer tissues, we would construct a combined model using machine learning and radiomics approaches. We sought to assess ...

Polycystic Ovary Syndrome (PCOS) is a prevalent hormonal condition, impacting approximately 8–13% of women worldwide, with profound effects on fertility, metabolism, and general health. Detecting ...

Anixa's ovarian cancer vaccine, being developed in a collaboration between Cleveland Clinic and the National Cancer Institute, represents a novel approach to preventing and treating ovarian cancer, ...

Recent advancements in artificial intelligence (AI) and transfer learning offer promising opportunities to improve diagnostic consistency and accuracy in ovarian disease detection.We introduced a new, ...

AbstractTo explore how early cancers can be detected prior to clinical signs or symptoms, we assessed prospectively collected serial plasma samples from the Atherosclerosis Risk in Communities study, ...